Opus Genetics, Inc. (IRD) Earnings
Opus Genetics, Inc. is expected to report next earnings on August 12, 2026 (in NaN days), with a consensus EPS estimate of $-0.15. IRD has beaten EPS estimates in 5 of its last 10 reported quarters (average surprise +13.4% over the last four).
Next earnings
Aug 12, 2026in NaN days
EPS est $-0.15 · Revenue est $3M
Track record
Beat EPS in 5 of 10 quarters
Avg surprise +13.4% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 21, 2026 | $-0.16 | $-0.19 | -18.8% | $4M | +22.9% |
| Nov 12, 2025 | $-0.14 | $-0.12 | +14.3% | $3M | +0.2% |
| Aug 13, 2025 | $-0.25 | $-0.12 | +52.0% | $3M | -6.5% |
| May 15, 2025 | $-0.34 | $-0.32 | +5.9% | $4M | +28.5% |
| Mar 31, 2025 | $-0.34 | $-1.27 | -273.5% | $4M | +27.0% |
| May 10, 2024 | $-0.18 | $-0.29 | -61.1% | $2M | -68.0% |
| Mar 8, 2024 | $-0.05 | $-0.22 | -315.2% | $2M | -68.4% |
| Nov 13, 2023 | $-0.22 | $0.25 | +211.8% | $12M | +294.5% |
| Jun 30, 2023 | $-0.23 | $-0.24 | -4.7% | $4M | +51.5% |
| Dec 31, 2022 | — | $1.58 | — | $40M | — |
| Sep 30, 2022 | $-0.28 | $-0.22 | +21.6% | — | — |
| Jun 30, 2022 | — | $-0.25 | — | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.